A federal jury on Thursday ordered Wyeth Pharmaceuticals and Upjohn Co. to pay more than $27 million to a Little Rock, Ark., woman who got breast cancer after taking hormone replacement therapy. The jury had ruled last month that the companies failed to adequately warn the plaintiff that the drugs carry an increased risk of breast cancer.
Read the rest of the article from Law.com and The Associated Press here...
Personal commentary: While $27 million may not be a crippling blow for the pharmaceutical industry, hopefully it - along with some other recent suits - will be enough to encourage manufacturers to reconsider their use of pregnant mares to make the hormones.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment